SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-001584
Filing Date
2013-01-03
Accepted
2013-01-03 19:01:31
Documents
1
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4102
  Complete submission text file 0001209191-13-001584.txt   5544
Mailing Address 10935 VISTA SORRENTO PARKWAY SUITE 250 SAN DIEGO CA 92130
Business Address 10935 VISTA SORRENTO PARKWAY SUITE 250 SAN DIEGO CA 92130 (858) 876-6500
Somaxon Pharmaceuticals, Inc. (Issuer) CIK: 0001339455 (see all company filings)

IRS No.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SOMAXON PHARMACEUTICALS, INC. 10935 VISTA SORRENTO PARKWAY, SUITE 250 SAN DIEGO CA 92130
Business Address
Onaitis Matthew (Reporting) CIK: 0001362822 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51665 | Film No.: 13509102